Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_21684 | 5 | 0.11 | Mlig455_014284, Mlig455_014320, Mlig455_014336 | Neo: - Age: logFC(26M/2M)=-0.541 |
HECA | Mlig455_014284 {REF} {Length: 1986} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} Mlig455_014320 {REF} {Length: 2086} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685, RNA1509_12340} {RNA1509_12340, RNA815_9766} Mlig455_014336 {REF} {Length: 2009} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=7e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=166, Expect=6e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | - | - | - | - | |
RegionR2 | - | - | - | - | |
RegionR3 | - | - | - | - | |
RegionR4 | - | - | - | - | |
RegionR5 | - | - | - | - | |
RegionR6 | - | - | - | - | |
RegionR7 | - | - | - | - | |
RegionR8 | - | - | - | - |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | - | - | - | - | |
RegenerationR2 | - | - | - | - | |
RegenerationR3 | - | - | - | - | |
RegenerationR4 | - | - | - | - | |
RegenerationR5 | - | - | - | - | |
RegenerationR6 | - | - | - | - | |
RegenerationBL | - | - | - | - | |
RegenerationTP | - | - | - | - |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_21684 | 5 | 0.11 | Mlig455_014284, Mlig455_014320, Mlig455_014336 | Neo: - Age: logFC(26M/2M)=-0.541 |
HECA | 3 | 1.000 | 1.000 | - | 1.000 | - | - | Mlig455_014284 {REF} {Length: 1986} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} Mlig455_014320 {REF} {Length: 2086} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685, RNA1509_12340} {RNA1509_12340, RNA815_9766} Mlig455_014336 {REF} {Length: 2009} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=7e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=166, Expect=6e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} |
2. | MligTC455_47927 | 43 | 0.9 | Mlig455_029720 | Neo: - Age: - |
1.873 | - | 1.000 | - | 0.873 | - | - | Mlig455_029720 {REF} {Length: 2459} {RNA1509_35671} {RNA1310_75812} {RNA815_33002} | |
3. | MligTC455_00070 | 11 | 0.23 | Mlig455_053401 | Neo: - Age: - |
1 | - | - | - | 1.000 | - | - | Mlig455_053401 {REF} {Length: 541} {NoTransDecoderORF} | |
4. | MligTC455_03372 | 14 | 0.29 | Mlig455_068642 | Neo: - Age: - |
1 | - | - | - | 1.000 | - | - | Mlig455_068642 {REF} {Length: 590} {NoTransDecoderORF} {RNA1509_6383} {RNA1310_56174} {RNA815_51778} | |
5. | MligTC455_03998 | 1 | 0.03 | Mlig455_002005, Mlig455_002098, Mlig455_002207 | Neo: - Age: - |
COL4A2 | 1 | - | - | - | 1.000 | - | - | Mlig455_002005 {REF} {Length: 671} {Pfam: Uncharacterized ACR, COG1993 [PF02641.17, score=23.5]} {Smed: dd_Smed_v6_64059_0_1, dd_Smed_v6_64059_0_1, [Score=45.1, Expect=6e-06]} {RNA1310_47066} Mlig455_002098 {REF} {Length: 778} {Pfam: Uncharacterized ACR, COG1993 [PF02641.17, score=24.4]} {Human: ENSG00000134871, COL4A2, collagen type IV alpha 2 chain, [Score=48.9, Expect=2e-06]} {Smed: dd_Smed_v6_64059_0_1, dd_Smed_v6_64059_0_1, [Score=49.3, Expect=2e-07]} {RNA1310_47066} Mlig455_002207 {REF} {Length: 654} {Pfam: Uncharacterized ACR, COG1993 [PF02641.17, score=22.6]} {RNA1310_47066} |
6. | MligTC455_06824 | 30 | 0.63 | Mlig455_033684 | Neo: - Age: - |
1 | - | - | - | 1.000 | - | - | Mlig455_033684 {REF} {Length: 521} {RNA1509_11770} {RNA1310_82896} | |
7. | MligTC455_07057 | 32 | 0.66 | Mlig455_062316, Mlig455_068910 | Neo: - Age: - |
1 | - | - | - | 1.000 | - | - | Mlig455_062316 {REF} {Length: 191} {NoTransDecoderORF} Mlig455_068910 {REF} {Length: 226} {NoTransDecoderORF} |
|
8. | MligTC455_08098 | 15 | 0.31 | Mlig455_029099 | Neo: - Age: - Region-enriched R2: 8.013/0.00338 |
1 | - | 1.000 | - | - | - | - | Mlig455_029099 {REF} {Length: 1334} {RNA1310_58776} {RNA815_46110} | |
9. | MligTC455_08408 | 41 | 0.86 | Mlig455_043171 | Neo: - Age: Up-Down-Down |
1 | - | 1.000 | - | - | - | - | Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360} | |
10. | MligTC455_08763 | 20 | 0.41 | Mlig455_061186 | Neo: - Age: - |
1 | - | 1.000 | - | - | - | - | Mlig455_061186 {REF} {Length: 1077} {Smed: dd_Smed_v6_13791_0_1, dd_Smed_v6_13791_0_1, [Score=96.3, Expect=3e-24]} {RNA1310_122132} | |
11. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 1 | - | 1.000 | - | - | - | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
12. | MligTC455_10227 | 76 | 1.59 | Mlig455_023507, Mlig455_023516, Mlig455_023551 | Neo: - Age: - |
1 | - | 1.000 | - | - | - | - | Mlig455_023507 {REF} {Length: 1545} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.8]} {RNA1310_22533.3} {RNA815_23050} Mlig455_023516 {REF} {Length: 1641} {RNA1310_22533.3} {RNA815_23050} Mlig455_023551 {REF} {Length: 1638} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_26724.1} |
|
13. | MligTC455_10229 | 24 | 0.49 | Mlig455_023615 | Neo: - Age: - |
1 | - | 1.000 | - | - | - | - | Mlig455_023615 {REF} {Length: 1635} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_23050} | |
14. | MligTC455_10810 | 6 | 0.12 | Mlig455_069505 | Neo: - Age: - |
1 | - | 1.000 | - | - | - | - | Mlig455_069505 {REF} {Length: 376} {NoTransDecoderORF} {RNA1310_40761} | |
15. | MligTC455_11441 | 4 | 0.08 | Mlig455_039364 | Neo: - Age: - |
1 | - | - | - | 1.000 | - | - | Mlig455_039364 {REF} {Length: 1132} | |
16. | MligTC455_11661 | 4 | 0.08 | Mlig455_019371, Mlig455_059103 | Neo: - Age: - |
1 | - | 1.000 | - | - | - | - | Mlig455_019371 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} Mlig455_059103 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} |
|
17. | MligTC455_12892 | 6 | 0.12 | Mlig455_010510, Mlig455_061868 | Neo: - Age: - |
1 | 1.000 | - | - | - | - | - | Mlig455_010510 {REF} {Length: 421} {NoTransDecoderORF} {RNA1310_125495} Mlig455_061868 {REF} {Length: 231} {NoTransDecoderORF} {RNA1310_125495} |
|
18. | MligTC455_13049 | 53 | 1.11 | Mlig455_029230, Mlig455_029252, Mlig455_035639, Mlig455_035735 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.077/0.00215 |
HTR2A | 1 | - | 1.000 | - | - | - | - | Mlig455_029230 {REF} {Length: 2756} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=149.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.0]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.6]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=24.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.2]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=142, Expect=3e-37]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=141, Expect=5e-37]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=138, Expect=8e-36]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=131, Expect=1e-32]} {Celegans: WBGene00004776, ser-1, SERotonin/octopamine receptor family; Serotonin receptor, [Score=120, Expect=2e-29]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=281, Expect=8e-90]} {RNA1310_91864} Mlig455_029252 {REF} {Length: 2844} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=188.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.8]; Spt20 family [PF12090.10, score=21.4]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=142, Expect=4e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=140, Expect=1e-35]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=136, Expect=2e-33]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=157, Expect=2e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=336, Expect=4e-108]} {RNA1310_91864} Mlig455_035639 {REF} {Length: 2811} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=182.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.7]; Spt20 family [PF12090.10, score=24.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=143, Expect=3e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=141, Expect=1e-35]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=133, Expect=6e-32]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=156, Expect=5e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=284, Expect=3e-88]} {RNA1310_91864} Mlig455_035735 {REF} {Length: 1469} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=140.9]; Spt20 family [PF12090.10, score=23.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=97.1, Expect=3e-21]; ENSG00000147246, HTR2C, 5-hydroxytryptamine receptor 2C, [Score=95.1, Expect=2e-20]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=95.5, Expect=1e-20]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=93.2, Expect=6e-20]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=89.0, Expect=2e-18]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=115, Expect=1e-27]} {Smed: dd_Smed_v6_31134_0_1, dd_Smed_v6_31134_0_1, [Score=249, Expect=4e-77]} {RNA1310_91864} |
19. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 1 | - | 1.000 | - | - | - | - | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
20. | MligTC455_20627 | 3 | 0.06 | Mlig455_058224 | Neo: - Age: - |
1 | 1.000 | - | - | - | - | - | Mlig455_058224 {REF} {Length: 117} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_25044} {RNA1310_17911} {RNA815_23396.1} | |
21. | MligTC455_26801 | 7 | 0.14 | Mlig455_024981 | Neo: - Age: - |
1 | - | 1.000 | - | - | - | - | Mlig455_024981 {REF} {Length: 847} {RNA1310_42506} {RNA815_41145} | |
22. | MligTC455_29492 | 3 | 0.06 | Mlig455_006012, Mlig455_066584, Mlig455_068087 | Neo: - Age: - |
1 | 1.000 | - | - | - | - | - | Mlig455_006012 {REF} {Length: 474} {NoTransDecoderORF} Mlig455_066584 {REF} {Length: 474} {NoTransDecoderORF} Mlig455_068087 {REF} {Length: 4735} {Pfam: Transposase [PF01498.20, score=19.6]} {RNA1509_19255} {RNA1310_1785} {RNA815_1942} |
|
23. | MligTC455_37412 | 95 | 1.98 | Mlig455_036605, Mlig455_036645 | Neo: - Age: - |
ADRA2A | 1 | - | 1.000 | - | - | - | - | Mlig455_036605 {REF} {Length: 3015} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.8]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=5e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=64.7, Expect=1e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=7e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=5e-35]} {RNA1310_57451} {RNA815_47300} Mlig455_036645 {REF} {Length: 3203} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.0]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=1e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=4e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=6e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=6e-35]} {RNA1310_57451} {RNA815_47300} |
24. | MligTC455_47997 | 36 | 0.75 | Mlig455_053262, Mlig455_065031 | Neo: - Age: - |
1 | - | 1.000 | - | - | - | - | Mlig455_053262 {REF} {Length: 927} {RNA1310_55950} {RNA815_42062.2} Mlig455_065031 {REF} {Length: 926} {RNA1310_55950} {RNA815_42062.2} |
|
25. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
0.999 | - | 0.999 | - | - | - | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
26. | MligTC455_10228 | 50 | 1.05 | Mlig455_023553 | Neo: - Age: - |
0.999 | - | 0.999 | - | - | - | - | Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050} | |
27. | MligTC455_36567 | 18 | 0.37 | Mlig455_065030 | Neo: - Age: - |
0.999 | - | 0.999 | - | - | - | - | Mlig455_065030 {REF} {Length: 672} | |
28. | MligTC455_12116 | 106 | 2.2 | Mlig455_004661, Mlig455_004728 | Neo: - Age: Up-Up-Down |
0.998 | - | 0.998 | - | - | - | - | Mlig455_004661 {REF} {Length: 3441} {RNA1509_48407} {RNA1310_2938.1} {RNA815_14343.2} Mlig455_004728 {REF} {Length: 2670} {RNA1509_48407} {RNA1310_45267.1, RNA1509_48407} {RNA1509_48407, RNA815_58661} |
|
29. | MligTC455_17266 | 62 | 1.3 | Mlig455_043650 | Neo: - Age: - |
0.998 | - | 0.998 | - | - | - | - | Mlig455_043650 {REF} {Length: 2826} {RNA1310_48878} {RNA815_25527} | |
30. | MligTC455_49188 | 2341 | 48.77 | Mlig455_002269, Mlig455_002314 | Neo: - Age: - Region-enriched R6: 6.536/0.00415 |
0.998 | - | - | - | 0.998 | - | - | Mlig455_002269 {REF} {Length: 959} {RNA1509_43329} {RNA1310_49486} {RNA815_5449} Mlig455_002314 {REF} {Length: 1882} {RNA1509_18874, RNA1509_2814, RNA1509_43329} {RNA1310_49486, RNA1509_18874, RNA1509_2814, RNA1509_43329} {RNA1509_18874, RNA1509_2814, RNA1509_43329, RNA815_5449} |
|
31. | MligTC455_17394 | 41 | 0.85 | Mlig455_013077 | Neo: - Age: - |
0.997 | - | 0.997 | - | - | - | - | Mlig455_013077 {REF} {Length: 1066} {RNA1310_66954} {RNA815_27868} | |
32. | MligTC455_49922 | 36 | 0.76 | Mlig455_049338 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.622/0.00496 |
0.997 | - | 0.997 | - | - | - | - | Mlig455_049338 {REF} {Length: 971} {RNA1310_37449} {RNA815_3585} | |
33. | MligTC455_53658 | 41 | 0.86 | Mlig455_070698 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.084/0.01491 |
0.997 | - | 0.997 | - | - | - | - | Mlig455_070698 {REF} {Length: 1026} {RNA1509_40972} {RNA1310_35649.1} {RNA815_17004} | |
34. | MligTC455_41443 | 382 | 7.96 | Mlig455_034791, Mlig455_034803 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.360 Region-enriched R2: 5.869/0.00205 |
0.996 | - | 0.996 | - | - | - | - | Mlig455_034791 {REF} {Length: 996} {RNA1310_39610.1} {RNA815_26421} Mlig455_034803 {REF} {Length: 1084} {RNA1310_39610.1} {RNA815_26421} |
|
35. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 0.995 | - | 0.995 | - | - | - | - | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
36. | MligTC455_38911 | 37 | 0.76 | Mlig455_052013 | Neo: - |
ANK3 | 0.995 | - | - | - | 0.995 | - | - | Mlig455_052013 {REF} {Length: 3708} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=144.6]; Ankyrin repeats (many copies) [PF13637.8, score=121.5]; Ankyrin repeat [PF00023.32, score=89.6]; Ankyrin repeat [PF13606.8, score=86.0]; Ankyrin repeats (many copies) [PF13857.8, score=79.5]; Mab-21 protein [PF03281.16, score=22.5]} {Human: ENSG00000151150, ANK3, ankyrin 3, [Score=138, Expect=3e-32]; ENSG00000029534, ANK1, ankyrin 1, [Score=138, Expect=2e-32]; ENSG00000145362, ANK2, ankyrin 2, [Score=132, Expect=3e-30]} {Mouse: ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=135, Expect=2e-31]; ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=132, Expect=1e-30]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=127, Expect=5e-29]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=117, Expect=2e-26]} {Smed: dd_Smed_v6_10835_0_2, dd_Smed_v6_10835_0_2, [Score=129, Expect=3e-30]} {RNA1509_38691} {RNA1310_6227} {RNA815_19191} |
37. | MligTC455_52527 | 28 | 0.58 | Mlig455_025836 | Neo: - Age: - |
FLVCR2 | 0.995 | - | 0.995 | - | - | - | - | Mlig455_025836 {REF} {Length: 2177} {TRANSSPLICED} {Pfam: Major Facilitator Superfamily [PF07690.18, score=81.4]; Sugar (and other) transporter [PF00083.26, score=18.7]} {Human: ENSG00000119686, FLVCR2, feline leukemia virus subgroup C cellular receptor family member 2, [RH, Score=364, Expect=5e-119]} {Mouse: ENSMUSG00000034258, Flvcr2, feline leukemia virus subgroup C cellular receptor 2, [RH, Score=367, Expect=3e-120]} {Dmel: FBgn0033196, CG1358, [RH, Score=350, Expect=1e-114]} {Celegans: WBGene00015632, C09D4.1, Uncharacterized MFS-type transporter C09D4.1, [RH, Score=358, Expect=1e-116]} {Smed: dd_Smed_v6_7578_0_1, dd_Smed_v6_7578_0_1, [Score=335, Expect=3e-109]} {RNA1509_31725} {RNA1310_8852.1} {RNA815_14234} |
38. | MligTC455_08407 | 22 | 0.46 | Mlig455_043162 | Neo: - Age: - |
0.994 | - | 0.994 | - | - | - | - | Mlig455_043162 {REF} {Length: 1257} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.7]} {RNA1310_58288} {RNA815_55196} | |
39. | MligTC455_13395 | 18 | 0.38 | Mlig455_061750 | Neo: - Age: - |
QRFPR | 0.994 | - | 0.994 | - | - | - | - | Mlig455_061750 {REF} {Length: 1579} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=107.1]} {Human: ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=99.8, Expect=2e-22]} {Mouse: ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=92.8, Expect=2e-20]} {Dmel: FBgn0050106, CCHa1-R, CCHamide-1 receptor, [Score=78.6, Expect=1e-15]} {Celegans: WBGene00021983, npr-5, NeuroPeptide Receptor family, [Score=77.4, Expect=2e-15]} {Smed: dd_Smed_v6_14520_0_1, dd_Smed_v6_14520_0_1, [Score=73.9, Expect=2e-14]} {RNA1310_103173} {RNA815_39338} |
40. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
0.994 | - | 0.994 | - | - | - | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
41. | MligTC455_52926 | 9 | 0.18 | Mlig455_024897 | Neo: - Age: - |
0.993 | - | 0.993 | - | - | - | - | Mlig455_024897 {REF} {Length: 428} {NoTransDecoderORF} {RNA1310_119495} | |
42. | MligTC455_15884 | 26 | 0.54 | Mlig455_066451 | Neo: - Age: - Region-enriched R2: 9.632/0.00394 |
0.992 | - | 0.992 | - | - | - | - | Mlig455_066451 {REF} {Length: 1468} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376} | |
43. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 0.992 | - | 0.992 | - | - | - | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
44. | MligTC455_23239 | 32 | 0.67 | Mlig455_030867 | Neo: - Age: - |
PRKCB | 0.992 | - | 0.992 | - | - | - | - | Mlig455_030867 {REF} {Length: 3999} {Pfam: Protein kinase domain [PF00069.27, score=228.1]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=131.0]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=118.5]; C2 domain [PF00168.32, score=93.9]; Protein kinase C terminal domain [PF00433.26, score=35.3]; C1 domain [PF03107.18, score=22.2]; Kinase-like [PF14531.8, score=19.0]} {Human: ENSG00000166501, PRKCB, protein kinase C beta, [RH, Score=962, Expect=0.0]; ENSG00000154229, PRKCA, protein kinase C alpha, [RH, Score=952, Expect=0.0]} {Mouse: ENSMUSG00000052889, Prkcb, protein kinase C, beta, [RH, Score=963, Expect=0.0]; ENSMUSG00000050965, Prkca, protein kinase C, alpha, [RH, Score=952, Expect=0.0]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [RH, Score=941, Expect=0.0]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [RH, Score=940, Expect=0.0]} {Smed: dd_Smed_v6_4244_0_2, dd_Smed_v6_4244_0_2, [RH, Score=1049, Expect=0.0]} {RNA1509_51260} {RNA1310_9698, RNA1509_51260} {RNA1509_51260, RNA815_24870} |
45. | MligTC455_49187 | 2581 | 53.77 | Mlig455_002170 | Neo: - Age: - Region-enriched R6: 6.621/0.00001 |
0.992 | - | - | - | 0.992 | - | - | Mlig455_002170 {REF} {Length: 748} {RNA1509_22237, RNA1509_6498} {RNA1310_49486, RNA1509_22237, RNA1509_6498} {RNA1509_22237, RNA1509_6498, RNA815_5449} | |
46. | MligTC455_07545 | 14 | 0.29 | Mlig455_001083 | Neo: - Age: - |
0.991 | 0.991 | - | - | - | - | - | Mlig455_001083 {REF} {Length: 859} {NoTransDecoderORF} {RNA1509_51478} {RNA1310_121350} {RNA815_4833.2} | |
47. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 0.991 | - | 0.991 | - | - | - | - | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
48. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 0.991 | - | 0.991 | - | - | - | - | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
49. | MligTC455_33850 | 80 | 1.67 | Mlig455_015720 | Neo: - Age: - Region-enriched R2: 4.134/0.00338 |
0.991 | - | 0.991 | - | - | - | - | Mlig455_015720 {REF} {Length: 829} {RNA1509_37932} {RNA1310_98453} | |
50. | MligTC455_08724 | 7 | 0.14 | Mlig455_008878 | Neo: - Age: - |
TENT5D | 0.99 | - | 0.990 | - | - | - | - | Mlig455_008878 {REF} {Length: 2482} {Pfam: Nucleotidyltransferase [PF07984.14, score=304.0]} {Human: ENSG00000174016, TENT5D, terminal nucleotidyltransferase 5D, [Score=248, Expect=8e-77]; ENSG00000183508, TENT5C, terminal nucleotidyltransferase 5C, [Score=246, Expect=4e-76]; ENSG00000112773, TENT5A, terminal nucleotidyltransferase 5A, [Score=239, Expect=1e-72]} {Mouse: ENSMUSG00000073007, Tent5d, terminal nucleotidyltransferase 5D, [Score=244, Expect=8e-76]; ENSMUSG00000044468, Tent5c, terminal nucleotidyltransferase 5C, [Score=243, Expect=3e-75]; ENSMUSG00000032265, Tent5a, terminal nucleotidyltransferase 5A, [Score=242, Expect=2e-74]} {Dmel: FBgn0050497, CG30497, [Score=244, Expect=2e-74]} {Celegans: WBGene00004131, pqn-44, Prion-like-(Q/N-rich)-domain-bearing protein, [RH, Score=209, Expect=2e-61]} {Smed: dd_Smed_v6_11571_0_1, dd_Smed_v6_11571_0_1, [Score=254, Expect=8e-80]} {RNA1310_116080} |
51. | MligTC455_12978 | 63 | 1.31 | Mlig455_023948 | Neo: - Age: - |
0.988 | - | 0.988 | - | - | - | - | Mlig455_023948 {REF} {Length: 2929} {RNA1310_80095.1} | |
52. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 0.988 | - | 0.988 | - | - | - | - | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
53. | MligTC455_23833 | 17 | 0.36 | Mlig455_016419 | Neo: - Age: - |
MYT1 | 0.988 | - | 0.988 | - | - | - | - | Mlig455_016419 {REF} {Length: 2682} {Pfam: Zinc finger, C2HC type [PF01530.20, score=79.8]} {Human: ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=130, Expect=1e-31]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=125, Expect=3e-30]} {Mouse: ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=132, Expect=6e-33]; ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=129, Expect=1e-31]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=126, Expect=2e-30]} {Dmel: FBgn0263772, CG43689, [RH, Score=99.0, Expect=1e-21]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=121, Expect=1e-29]} {Smed: dd_Smed_v6_80183_0_2, dd_Smed_v6_80183_0_2, [Score=127, Expect=4e-34]} {RNA1310_143021} |
54. | MligTC455_33853 | 7 | 0.14 | Mlig455_029940 | Neo: - Age: - |
MGAT1 | 0.988 | - | 0.988 | - | - | - | - | Mlig455_029940 {REF} {Length: 2088} {Pfam: GNT-I family [PF03071.17, score=204.9]} {Human: ENSG00000131446, MGAT1, mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase, [Score=153, Expect=4e-41]} {Mouse: ENSMUSG00000020346, Mgat1, mannoside acetylglucosaminyltransferase 1, [Score=166, Expect=4e-46]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=172, Expect=3e-48]} {Celegans: WBGene00001639, gly-14, GLYcosylation related; UDP-N-acetylglucosamine:a-3-D-mannoside b-1,2-N-acetylglucosaminyltransferase I, [Score=144, Expect=2e-38]} {Smed: dd_Smed_v6_13024_0_1, dd_Smed_v6_13024_0_1, [Score=158, Expect=1e-43]} {RNA1310_114996} |
55. | MligTC455_37444 | 4098 | 85.37 | Mlig455_005616, Mlig455_014433, Mlig455_057559, Mlig455_070182 | Neo: - Age: - Region-enriched R2: 1.909/0.00760 |
0.987 | - | 0.987 | - | - | - | - | Mlig455_005616 {REF} {Length: 641} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1} {RNA815_13049.1} Mlig455_014433 {REF} {Length: 626} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1} {RNA815_13049.1} Mlig455_057559 {REF} {Length: 1151} {RNA1310_107958} Mlig455_070182 {REF} {Length: 638} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1, RNA1509_33612} {RNA1509_33612, RNA815_13049.1} |
|
56. | MligTC455_13903 | 648 | 13.5 | Mlig455_013116 | Neo: - Age: logFC(26M/2M)=-1.026 Region-specific R2: 6.980 Region-enriched R2: 7.338/0.00000 |
0.986 | - | 0.986 | - | - | - | - | Mlig455_013116 {REF} {Length: 914} {RNA1509_28527} {RNA1310_38436.2, RNA1509_28527} {RNA1509_28527, RNA815_28856} | |
57. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
0.985 | - | 0.985 | - | - | - | - | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
58. | MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | 0.985 | - | 0.985 | - | - | - | - | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |
59. | MligTC455_53586 | 32 | 0.66 | Mlig455_061060 | Neo: - Age: - |
0.985 | - | 0.985 | - | - | - | - | Mlig455_061060 {REF} {Length: 1466} {RNA1310_93934} {RNA815_37442} | |
60. | MligTC455_12894 | 84 | 1.75 | Mlig455_024418, Mlig455_024572 | Neo: - Age: - Region-enriched R2: 5.211/0.02671 |
SLC46A2 | 0.984 | - | 0.984 | - | - | - | - | Mlig455_024418 {REF} {Length: 2094} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_44254} {RNA815_43004} Mlig455_024572 {REF} {Length: 1344} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_71457} {RNA815_15082} |
61. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
0.984 | - | 0.984 | - | - | - | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
62. | MligTC455_35103 | 102 | 2.12 | Mlig455_023928 | Neo: - Age: logFC(26M/2M)=-1.570 Region-enriched R2: 8.161/0.00000 |
OPN4 | 0.983 | - | 0.983 | - | - | - | - | Mlig455_023928 {REF} {Length: 2781} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=179.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=34.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=24.6]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.1]} {Human: ENSG00000122375, OPN4, opsin 4, [RH, Score=218, Expect=2e-65]} {Mouse: ENSMUSG00000021799, Opn4, opsin 4 (melanopsin), [RH, Score=225, Expect=1e-68]} {Dmel: FBgn0014019, Rh5, Rhodopsin 5, [RH, Score=222, Expect=2e-68]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=91.3, Expect=4e-20]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [RH, Score=520, Expect=0.0]} {RNA1509_41123} {RNA1310_10673, RNA1509_41123} {RNA1509_41123, RNA815_4962} |
63. | MligTC455_46281 | 22 | 0.45 | Mlig455_016138 | Neo: Irradiation Age: - |
KDELR2 | 0.983 | - | 0.983 | - | - | - | - | Mlig455_016138 {REF} {Length: 2664} {TRANSSPLICED} {Pfam: ER lumen protein retaining receptor [PF00810.20, score=173.9]; Intermediate filament protein [PF00038.23, score=132.5]; Lamin Tail Domain [PF00932.21, score=37.2]} {Human: ENSG00000136240, KDELR2, KDEL endoplasmic reticulum protein retention receptor 2, [Score=293, Expect=2e-93]} {Mouse: ENSMUSG00000079111, Kdelr2, KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2, [Score=296, Expect=1e-94]} {Dmel: FBgn0267330, KdelR, KDEL receptor, [Score=291, Expect=4e-93]} {Celegans: WBGene00001331, erd-2, ER lumen protein-retaining receptor, [Score=266, Expect=2e-83]} {Smed: dd_Smed_v6_1592_0_1, dd_Smed_v6_1592_0_1, [Score=283, Expect=8e-90]} {RNA1509_3479} {RNA1310_8292} {RNA815_3092.1} |
64. | MligTC455_12886 | 7 | 0.15 | Mlig455_062770 | Neo: - Age: - |
0.982 | - | 0.982 | - | - | - | - | Mlig455_062770 {REF} {Length: 486} {RNA1310_94667} | |
65. | MligTC455_36566 | 40 | 0.83 | Mlig455_053263 | Neo: - Age: - Region-enriched R2: 4.823/0.01830 |
0.982 | - | 0.982 | - | - | - | - | Mlig455_053263 {REF} {Length: 1228} {TRANSSPLICED} {RNA1310_99871} | |
66. | MligTC455_05659 | 9 | 0.19 | Mlig455_000779 | Neo: - Age: - |
0.98 | - | 0.980 | - | - | - | - | Mlig455_000779 {REF} {Length: 525} {RNA1509_14736} {RNA1310_6965} {RNA815_41421} | |
67. | MligTC455_12269 | 42 | 0.88 | Mlig455_062448 | Neo: - Age: - Region-enriched R2: 6.351/0.02912 |
0.98 | - | 0.980 | - | - | - | - | Mlig455_062448 {REF} {Length: 941} {RNA1310_43338} {RNA815_24238} | |
68. | MligTC455_16342 | 20 | 0.42 | Mlig455_012507 | Neo: - Age: - |
0.98 | - | 0.980 | - | - | - | - | Mlig455_012507 {REF} {Length: 1825} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=61.0]} {Smed: dd_Smed_v6_14020_0_1, dd_Smed_v6_14020_0_1, [RH, Score=132, Expect=2e-38]} {RNA1509_23873} {RNA1310_73480} {RNA815_38079} | |
69. | MligTC455_37870 | 8 | 0.18 | Mlig455_013912, Mlig455_042223, Mlig455_042495 | Neo: Int S/G2/M Age: Down-Up-Down |
FCN2 | 0.98 | - | - | - | 0.980 | - | - | Mlig455_013912 {REF} {Length: 1493} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=39.7]} {Smed: dd_Smed_v6_129_2_2, dd_Smed_v6_129_2_2, [Score=136, Expect=3e-37]} {RNA1509_28547} {RNA1310_33803.1} {RNA815_30600} Mlig455_042223 {REF} {Length: 2428} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=41.0]} {Smed: dd_Smed_v6_129_2_2, dd_Smed_v6_129_2_2, [RH, Score=250, Expect=9e-75]} {RNA1509_28547} {RNA1310_33803.1} {RNA815_30600} Mlig455_042495 {REF} {Length: 1039} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=100.4]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=79.3, Expect=6e-17]; ENSG00000167772, ANGPTL4, angiopoietin like 4, [Score=79.3, Expect=1e-16]; ENSG00000085265, FCN1, ficolin 1, [Score=78.2, Expect=3e-16]; ENSG00000171564, FGB, fibrinogen beta chain, [Score=77.4, Expect=3e-16]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=76.6, Expect=2e-15]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=77.8, Expect=5e-16]; ENSMUSG00000033831, Fgb, fibrinogen beta chain, [Score=76.6, Expect=1e-15]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=75.1, Expect=2e-15]} {Dmel: FBgn0087011, CG41520, [Score=73.9, Expect=8e-15]} {RNA1509_28547} {RNA1310_111580} {RNA815_12221} |
70. | MligTC455_53657 | 221 | 4.6 | Mlig455_039396 | Neo: - Age: - Region-enriched R2: 6.078/0.00340 |
0.98 | - | 0.980 | - | - | - | - | Mlig455_039396 {REF} {Length: 1026} {Pfam: emp24/gp25L/p24 family/GOLD [PF01105.26, score=21.0]} {RNA1509_40972} {RNA1310_35649.1, RNA1509_40972} {RNA1509_40972, RNA815_17004} | |
71. | MligTC455_35000 | 20 | 0.42 | Mlig455_050562 | Neo: - Age: - |
KCNC1 | 0.979 | - | 0.979 | - | - | - | - | Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040} |
72. | MligTC455_11109 | 30 | 0.62 | Mlig455_043718, Mlig455_043804 | Neo: - Age: Up-Down-Down |
0.978 | - | 0.978 | - | - | - | - | Mlig455_043718 {REF} {Length: 1591} {RNA1310_49834.1} {RNA815_39415} Mlig455_043804 {REF} {Length: 1594} {RNA1310_49834.2} {RNA815_39415} |
|
73. | MligTC455_41207 | 52 | 1.08 | Mlig455_011309, Mlig455_060938 | Neo: - Age: - |
0.978 | - | - | - | 0.978 | - | - | Mlig455_011309 {REF} {Length: 76} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_22660} {RNA1310_12928.1} {RNA815_18634} Mlig455_060938 {REF} {Length: 68} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_22660} {RNA1310_12928.1} {RNA815_18634} |
|
74. | MligTC455_16024 | 145 | 3.02 | Mlig455_000879 | Neo: - Age: logFC(26M/2M)=0.299 |
IDE | 0.977 | - | - | - | 0.977 | - | - | Mlig455_000879 {REF} {Length: 4663} {Pfam: Middle or third domain of peptidase_M16 [PF16187.7, score=280.9]; Insulinase (Peptidase family M16) [PF00675.22, score=142.4]; Peptidase M16 inactive domain [PF05193.23, score=89.0]} {Human: ENSG00000119912, IDE, insulin degrading enzyme, [RH, Score=719, Expect=0.0]} {Mouse: ENSMUSG00000056999, Ide, insulin degrading enzyme, [RH, Score=726, Expect=0.0]; ENSMUSG00000111624, Ide, insulin degrading enzyme, [RH, Score=726, Expect=0.0]} {Dmel: FBgn0001247, Ide, Insulin degrading metalloproteinase, [RH, Score=693, Expect=0.0]} {Celegans: WBGene00018426, F44E7.4, [RH, Score=582, Expect=0.0]} {Smed: dd_Smed_v6_9500_1_1, dd_Smed_v6_9500_1_1, [RH, Score=603, Expect=0.0]} {RNA1509_3150} {RNA1310_856.2} {RNA815_1063} |
75. | MligTC455_41722 | 271 | 5.65 | Mlig455_058499 | Neo: - |
0.977 | - | 0.977 | - | - | - | - | Mlig455_058499 {REF} {Length: 634} {RNA1509_12988, RNA1509_17403} {RNA1310_82552.1, RNA1509_12988, RNA1509_17403} {RNA1509_12988, RNA1509_17403, RNA815_43140.1} | |
76. | MligTC455_47197 | 155 | 3.24 | Mlig455_049096, Mlig455_049118 | Neo: - Age: - |
0.977 | - | 0.977 | - | - | - | - | Mlig455_049096 {REF} {Length: 3209} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=151, Expect=1e-37]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} Mlig455_049118 {REF} {Length: 3116} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=160, Expect=1e-40]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} |
|
77. | MligTC455_49303 | 64 | 1.33 | Mlig455_058897 | Neo: - Age: - |
SALL3 | 0.977 | - | 0.977 | - | - | - | - | Mlig455_058897 {REF} {Length: 4598} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=70.9]; C2H2-type zinc finger [PF13894.8, score=55.8]; Zinc-finger double domain [PF13465.8, score=55.4]; Zinc-finger of C2H2 type [PF12874.9, score=45.8]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=39.1]} {Human: ENSG00000256463, SALL3, spalt like transcription factor 3, [Score=92.4, Expect=3e-18]; ENSG00000277015, SALL3, spalt like transcription factor 3, [Score=92.4, Expect=3e-18]; ENSG00000263310, SALL3, spalt like transcription factor 3, [Score=92.4, Expect=3e-18]; ENSG00000101115, SALL4, spalt like transcription factor 4, [Score=91.3, Expect=5e-18]; ENSG00000130856, ZNF236, zinc finger protein 236, [Score=90.9, Expect=1e-17]; ENSG00000103449, SALL1, spalt like transcription factor 1, [Score=90.1, Expect=2e-17]} {Mouse: ENSMUSG00000024565, Sall3, spalt like transcription factor 3, [Score=92.0, Expect=2e-18]; ENSMUSG00000027547, Sall4, spalt like transcription factor 4, [Score=91.7, Expect=3e-18]; ENSMUSG00000031665, Sall1, spalt like transcription factor 1, [Score=90.1, Expect=1e-17]} {Dmel: FBgn0261648, salm, spalt major, [RH, Score=97.4, Expect=5e-20]} {Celegans: WBGene00004773, sem-4, SEM-4 long form, [RH, Score=97.4, Expect=2e-20]} {Smed: dd_Smed_v6_14176_0_1, dd_Smed_v6_14176_0_1, [RH, Score=121, Expect=2e-28]} {RNA1310_43057} {RNA815_29425} |
78. | MligTC455_12607 | 22 | 0.46 | Mlig455_022861 | Neo: - Age: - |
0.972 | - | 0.972 | - | - | - | - | Mlig455_022861 {REF} {Length: 614} {TRANSSPLICED} {RNA1310_92283} | |
79. | MligTC455_50092 | 140 | 2.92 | Mlig455_041942 | Neo: Irradiation Age: - |
RNF216 | 0.972 | - | - | - | 0.972 | - | - | Mlig455_041942 {REF} {Length: 2906} {TRANSSPLICED} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=26.8]} {Human: ENSG00000011275, RNF216, ring finger protein 216, [Score=176, Expect=1e-45]} {Mouse: ENSMUSG00000045078, Rnf216, ring finger protein 216, [Score=173, Expect=5e-45]} {Dmel: FBgn0025186, ari-2, ariadne 2, [Score=61.6, Expect=1e-09]} {Celegans: WBGene00016157, C27A12.7, [Score=68.9, Expect=5e-12]} {Smed: dd_Smed_v6_4224_0_1, dd_Smed_v6_4224_0_1, [Score=63.9, Expect=1e-10]} {RNA1509_15865} {RNA1310_11127, RNA1509_15865} {RNA1509_15865, RNA815_4010.1} |
80. | MligTC455_21178 | 29 | 0.59 | Mlig455_001203, Mlig455_066754, Mlig455_069710 | Neo: - Age: Down-Up-Down |
CCKAR, NPFFR1 | 0.971 | - | 0.971 | - | - | - | - | Mlig455_001203 {REF} {Length: 4789} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=109.9]} {Human: ENSG00000163394, CCKAR, cholecystokinin A receptor, [Score=60.5, Expect=3e-09]; ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=58.5, Expect=9e-09]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=59.3, Expect=3e-09]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=58.2, Expect=4e-09]; ENSMUSG00000029193, Cckar, cholecystokinin A receptor, [Score=56.6, Expect=3e-08]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=56.6, Expect=2e-08]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=65.5, Expect=4e-11]} {Celegans: WBGene00004778, ser-3, SERotonin/octopamine receptor family, [Score=58.5, Expect=5e-09]} {Smed: dd_Smed_v6_43180_0_1, dd_Smed_v6_43180_0_1, [Score=72.4, Expect=4e-14]} {RNA1310_113134} Mlig455_066754 {REF} {Length: 3197} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=84.3]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=52.8, Expect=6e-07]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0038542, TyrR, Tyramine receptor, [Score=53.5, Expect=2e-07]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=50.1, Expect=1e-06]} {Smed: dd_Smed_v6_16725_0_1, dd_Smed_v6_16725_0_1, [Score=52.8, Expect=2e-07]} {RNA1310_131269} Mlig455_069710 {REF} {Length: 1208} {NoTransDecoderORF} {RNA1310_131269} |
81. | MligTC455_37701 | 47 | 0.98 | Mlig455_029831 | Neo: - Age: - Region-enriched R2: 8.298/0.02665 |
0.971 | - | 0.971 | - | - | - | - | Mlig455_029831 {REF} {Length: 724} {RNA1310_73844} | |
82. | MligTC455_23220 | 56 | 1.18 | Mlig455_060190 | Neo: - Age: - |
ACKR3 | 0.969 | - | 0.969 | - | - | - | - | Mlig455_060190 {REF} {Length: 2108} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.0]} {Human: ENSG00000144476, ACKR3, atypical chemokine receptor 3, [RH, Score=99.0, Expect=1e-22]} {Mouse: ENSMUSG00000026180, Cxcr2, chemokine (C-X-C motif) receptor 2, [Score=112, Expect=1e-27]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=102, Expect=4e-24]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=81.6, Expect=5e-17]} {RNA1310_66504} {RNA815_39432} |
83. | MligTC455_00555 | 15 | 0.31 | Mlig455_012173 | Neo: - Age: - |
RPTN | 0.968 | - | - | - | 0.968 | - | - | Mlig455_012173 {REF} {Length: 962} {Pfam: Domain of unknown function (DUF4573) [PF15140.8, score=19.1]} {Human: ENSG00000215853, RPTN, repetin, [Score=49.3, Expect=2e-07]} {Mouse: ENSMUSG00000052415, Tchh, trichohyalin, [Score=52.8, Expect=1e-08]} {RNA1310_68353.1} |
84. | MligTC455_47114 | 14 | 0.29 | Mlig455_032836 | Neo: - Age: - |
0.968 | - | - | - | 0.968 | - | - | Mlig455_032836 {REF} {Length: 265} {NoTransDecoderORF} {RNA1310_64101} {RNA815_38499} | |
85. | MligTC455_52925 | 10 | 0.21 | Mlig455_024819 | Neo: - Age: - |
0.968 | - | 0.968 | - | - | - | - | Mlig455_024819 {REF} {Length: 433} {NoTransDecoderORF} {RNA1310_119495} | |
86. | MligTC455_17912 | 11 | 0.24 | Mlig455_039803 | Neo: - Age: - |
GLRA2 | 0.967 | 0.967 | - | - | - | - | - | Mlig455_039803 {REF} {Length: 2675} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=112.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=90.4]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=275, Expect=1e-87]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=269, Expect=3e-85]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=268, Expect=6e-85]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=275, Expect=9e-88]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=271, Expect=7e-86]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=264, Expect=2e-83]} {Dmel: FBgn0024963, GluClalpha, [Score=260, Expect=2e-82]} {Celegans: WBGene00000232, avr-14, Inhibitory amino acid receptor subunit gbr-2A, [Score=246, Expect=2e-77]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=223, Expect=3e-68]} {RNA1310_60887} |
87. | MligTC455_10578 | 11 | 0.24 | Mlig455_063647 | Neo: - Age: - |
0.966 | - | 0.966 | - | - | - | - | Mlig455_063647 {REF} {Length: 394} {NoTransDecoderORF} {RNA1310_102533} {RNA815_12221} | |
88. | MligTC455_49285 | 164 | 3.41 | Mlig455_004486, Mlig455_037380 | Neo: - Age: - Region-specific R2: 6.095 Region-enriched R2: 5.942/0.00244 |
LEF1 | 0.966 | - | 0.966 | - | - | - | - | Mlig455_004486 {REF} {Length: 3612} {Pfam: HMG (high mobility group) box [PF00505.21, score=30.1]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [Score=105, Expect=2e-24]; ENSG00000081059, TCF7, transcription factor 7, [Score=103, Expect=3e-25]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [Score=100, Expect=2e-22]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [Score=105, Expect=6e-25]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [Score=101, Expect=8e-24]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [Score=100, Expect=1e-22]} {Dmel: FBgn0085432, pan, pangolin, [Score=103, Expect=1e-23]} {Celegans: WBGene00004077, pop-1, [Score=82.0, Expect=8e-17]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [Score=114, Expect=3e-29]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141} Mlig455_037380 {REF} {Length: 3365} {Pfam: HMG (high mobility group) box [PF00505.21, score=78.7]; HMG-box domain [PF09011.12, score=32.5]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=156, Expect=1e-43]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=154, Expect=7e-41]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=154, Expect=3e-44]; ENSG00000148737, TCF7L2, transcription factor 7 like 2, [RH, Score=150, Expect=6e-44]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=157, Expect=9e-44]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=156, Expect=1e-41]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=153, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=155, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=104, Expect=4e-24]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=165, Expect=2e-48]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141} |
89. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
0.964 | - | 0.964 | - | - | - | - | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
90. | MligTC455_53044 | 9 | 0.18 | Mlig455_000012 | Neo: - Age: - |
0.964 | 0.964 | - | - | - | - | - | Mlig455_000012 {REF} {Length: 1005} {RNA1509_48973} {RNA1310_38998.3} {RNA815_43662} | |
91. | MligTC455_14059 | 24 | 0.5 | Mlig455_037086 | Neo: - Age: - Region-enriched R2: 8.935/0.00338 |
0.962 | - | 0.962 | - | - | - | - | Mlig455_037086 {REF} {Length: 1622} {Pfam: Galactosyltransferase [PF01762.23, score=18.6]} {RNA1310_57689} {RNA815_57743} | |
92. | MligTC455_44725 | 67 | 1.4 | Mlig455_024194 | Neo: - Age: - |
0.962 | - | 0.962 | - | - | - | - | Mlig455_024194 {REF} {Length: 956} {RNA1310_84543} {RNA815_47586} | |
93. | MligTC455_05958 | 6 | 0.12 | Mlig455_045904 | Neo: - Age: - |
0.961 | - | - | - | 0.961 | - | - | Mlig455_045904 {REF} {Length: 260} {NoTransDecoderORF} | |
94. | MligTC455_09025 | 12 | 0.25 | Mlig455_003794, Mlig455_065651, Mlig455_067766 | Neo: Int S/G2/M Age: - |
0.961 | - | - | - | 0.961 | - | - | Mlig455_003794 {REF} {Length: 273} {NoTransDecoderORF} {RNA1310_75832} {RNA815_49210.1} Mlig455_065651 {REF} {Length: 634} {NoTransDecoderORF} {RNA1310_93677} {RNA815_49210.1} Mlig455_067766 {REF} {Length: 1058} {RNA1310_75832} {RNA815_49210.1} |
|
95. | MligTC455_34107 | 20 | 0.41 | Mlig455_007756, Mlig455_036623, Mlig455_058157 | Neo: Germline Age: - |
0.961 | - | - | - | 0.961 | - | - | Mlig455_007756 {REF} {Length: 3485} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=113.9]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=112.3]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=91.1]; Integrase zinc binding domain [PF17921.3, score=67.7]; Integrase core domain [PF00665.28, score=45.7]; H2C2 zinc finger [PF09337.12, score=29.1]} {Smed: dd_Smed_v6_1574_6_43, dd_Smed_v6_1574_6_43, [RH, Score=382, Expect=4e-120]} {RNA1509_34066} {RNA1310_1125} {RNA815_16355} Mlig455_036623 {REF} {Length: 3485} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=113.8]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=112.2]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=91.9]; Integrase zinc binding domain [PF17921.3, score=67.5]; Integrase core domain [PF00665.28, score=45.5]; H2C2 zinc finger [PF09337.12, score=29.0]; gag-polyprotein putative aspartyl protease [PF13975.8, score=26.5]; Aspartyl protease [PF13650.8, score=22.7]; Retroviral aspartyl protease [PF00077.22, score=19.9]} {Smed: dd_Smed_v6_1574_6_38, dd_Smed_v6_1574_6_38, [RH, Score=382, Expect=7e-119]} {RNA1509_34066} {RNA1310_1125} {RNA815_16355} Mlig455_058157 {REF} {Length: 6548} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=113.4]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=111.7]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=90.9]; Integrase zinc binding domain [PF17921.3, score=64.2]; Integrase core domain [PF00665.28, score=45.0]; gag-polyprotein putative aspartyl protease [PF13975.8, score=28.6]; H2C2 zinc finger [PF09337.12, score=28.1]; Aspartyl protease [PF13650.8, score=23.6]; Retroviral aspartyl protease [PF00077.22, score=19.0]} {Smed: dd_Smed_v6_1574_6_38, dd_Smed_v6_1574_6_38, [RH, Score=379, Expect=1e-115]} {RNA1509_34066} {RNA1310_1125} {RNA815_16355} |
|
96. | MligTC455_47110 | 34 | 0.7 | Mlig455_025028 | Neo: - Age: - |
0.961 | - | 0.961 | - | - | - | - | Mlig455_025028 {REF} {Length: 521} {RNA1509_55651} {RNA1310_59019} {RNA815_42240} | |
97. | MligTC455_14689 | 16 | 0.34 | Mlig455_042558 | Neo: - Age: - |
0.96 | - | - | - | 0.960 | - | - | Mlig455_042558 {REF} {Length: 1489} {NoTransDecoderORF} {RNA1509_4484} {RNA1310_55711.2} {RNA815_43533} | |
98. | MligTC455_20428 | 37 | 0.78 | Mlig455_050428 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.829/0.00010 |
LRRN3 | 0.959 | - | 0.959 | - | - | - | - | Mlig455_050428 {REF} {Length: 10329} {Pfam: Leucine rich repeat [PF13855.8, score=96.2]; Leucine Rich repeats (2 copies) [PF12799.9, score=63.4]; Immunoglobulin domain [PF13927.8, score=44.7]; Immunoglobulin I-set domain [PF07679.18, score=41.3]; Immunoglobulin domain [PF00047.27, score=31.4]; Leucine-rich repeat [PF14580.8, score=24.8]; Immunoglobulin V-set domain [PF07686.19, score=23.1]; Immunoglobulin domain [PF13895.8, score=22.9]; Leucine Rich Repeat [PF00560.35, score=20.8]} {Human: ENSG00000173114, LRRN3, leucine rich repeat neuronal 3, [RH, Score=114, Expect=2e-25]; ENSG00000174482, LINGO2, leucine rich repeat and Ig domain containing 2, [RH, Score=112, Expect=3e-25]; ENSG00000175928, LRRN1, leucine rich repeat neuronal 1, [RH, Score=111, Expect=2e-24]} {Mouse: ENSMUSG00000036295, Lrrn3, leucine rich repeat protein 3, neuronal, [RH, Score=113, Expect=2e-25]; ENSMUSG00000045083, Lingo2, leucine rich repeat and Ig domain containing 2, [RH, Score=110, Expect=1e-24]; ENSMUSG00000034648, Lrrn1, leucine rich repeat protein 1, neuronal, [RH, Score=108, Expect=5e-24]} {Dmel: FBgn0032479, CG16974, [Score=89.0, Expect=1e-17]} {Celegans: WBGene00020649, sma-10, Leucine-rich repeats and immunoglobulin-like domains protein sma-10, [Score=73.6, Expect=4e-13]} {RNA1509_34876} {RNA1310_313, RNA1509_34876} {RNA1509_34876, RNA815_2616} |
99. | MligTC455_20757 | 286 | 5.96 | Mlig455_005125, Mlig455_005185 | Neo: - Age: - |
0.959 | - | 0.959 | - | - | - | - | Mlig455_005125 {REF} {Length: 1290} {RNA1310_29676.2} {RNA815_31533} Mlig455_005185 {REF} {Length: 1357} {RNA1310_29676.1} {RNA815_31533} |
|
100. | MligTC455_34497 | 50 | 1.03 | Mlig455_057540, Mlig455_058243, Mlig455_068776, Mlig455_069555 | Neo: - Age: - |
0.959 | - | - | - | 0.959 | - | - | Mlig455_057540 {REF} {Length: 1160} {NoTransDecoderORF} {RNA1509_52345} {RNA1310_90874} {RNA815_25651.2} Mlig455_058243 {REF} {Length: 682} {NoTransDecoderORF} {RNA1310_33089.1} {RNA815_25651.2} Mlig455_068776 {REF} {Length: 1284} {NoTransDecoderORF} {RNA1310_33089.1} {RNA815_25651.2} Mlig455_069555 {REF} {Length: 973} {NoTransDecoderORF} {RNA1509_10641} {RNA1310_33089.1} {RNA815_25651.2} |